Testing effectiveness (Phase 2)Looking for participantsNCT05398809
What this trial is testing
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Who this might be right for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)Alopecia Areata
National Institute of Allergy and Infectious Diseases (NIAID) 70